Bovela
Active substance
ATC code
Species
Cattle
Indications
For active immunisation of cattle from 3 months of age to reduce hyperthermia and to minimise the reduction of leukocyte count caused by bovine viral diarrhoea virus (BVDV-1 and BVDV-2), and to reduce virus shedding and viraemia caused by BVDV-2.
For active immunisation of cattle against BVDV-1 and BVDV-2, to prevent the birth of persistently infected calves caused by transplacental infection.
|
Onset of immunity: |
3 weeks after immunisation. |
|
Duration of immunity: |
1 year after immunisation. |
Dose to be administered and administration route
Intramuscular use.
Preparation of vaccine for use (reconstitution):
Reconstitute the lyophilisate by adding the full content of the solvent at room temperature.
Ensure that the lyophilisate is completely reconstituted before use.
The reconstituted vaccine is transparent and colourless. Avoid multiple broaching.
Primary vaccination:
After reconstitution, administer one dose (2 ml) of the vaccine by intramuscular (IM) injection.
It is recommended to vaccinate cattle at least 3 weeks before insemination/mating to provide foetal protection from the first day of conception. Animals which are vaccinated later than 3 weeks before gestation or during the early gestation may not be protected against foetal infection. This should be considered in case of herd vaccination.
Recommended re-vaccination programme:
Revaccination is recommended after 1 year.
12 months after primary vaccination most studied animals still had antibody titres at plateau while some animals had lower titres.
Adverse reactions
Target species: cattle
|
Common (1 to 10 animals / 100 animals treated): |
Elevated temperature* |
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Injection site swelling or Injection site nodule** Hypersensitivity reaction including anaphylactictype reaction. |
*within the physiological range is common within 4 hours of vaccination, resolving within 24 hours**≤ 3 cm in diameter, resolving within 4 days after vaccination
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also the last section of the package leaflet for respective contact details.
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 04491/5004 |
| EAN | 5012917040029 |
